Synthesis of the Antiviral Nucleotide Analogue ddhCTP

  • Author: Sarah Maier
  • Published: 21 June 2021
  • Copyright: Wiley-VCH GmbH
  • Associated Societies: American Chemical Society (ACS), USA
thumbnail image: Synthesis of the Antiviral Nucleotide Analogue ddhCTP

The emergence of new viral diseases like COVID-19 is a great challenge for public health. When a new virus begins to infect people, specific treatments and vaccinations are not available yet. Therefore, broad-spectrum antiviral drugs could be important tools for controlling the spread of such diseases.

3'-Deoxy-3',4'-didehydro-cytidine triphosphate (ddhCTP, pictured) is a naturally occurring antiviral nucleotide analogue that is produced by the enzyme viperin in vivo and has been shown to act against different viral pathogens, including SARS-CoV-2. However, the bioenzymatic synthesis using isolated viperin only gives small yields, which are not sufficient for a full evaluation of the biological activities of ddhCTP and its derivatives.

Lawrence D. Harris, Victoria University of Wellington and The University of Auckland, both New Zealand, and colleagues have developed a chemical synthesis route to ddhCTP using an eight-step reaction sequence with an overall yield of 19 %, starting from commercially available 4-N-benzoylcytidine. The selective conversion of this starting material requires the use of additional protecting groups. The team chose a tert-butyldimethylsilyl (TBDMS) group, whose lipophilic silyl groups could also simplify the chromatographic purification of the phosphorylated product. The 3'-deoxy-3',4'-didehydroribo unit was formed by iodination at the 3'-position of the 4-N-benzoylcytidine ribose ring and a subsequent base-mediated elimination of HI.

The choice of the silyl protecting group strategy proved effective, enabling rapid reverse-phase chromatographic purification of the product after phosphorylation—instead of the challenging ion-exchange chromatography methods required for the purification of similar compounds. The removal of the protecting groups was carried out smoothly under mild conditions. The developed synthesis route provides sufficient quantities of phosphorylated ddhC derivatives, including ddhCTP, to enable further biological studies.



Article Views: 1185

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permisson guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH